top of page

The Tedesco laboratory studies skeletal muscle regeneration, focusing on the development of novel therapies for incurable neuromuscular disorders of childhood. They work pioneered the use of cutting-edge technologies such as human induced pluripotent stem (iPS) cells, artificial chromosomes and tissue engineering for advanced disease modelling and gene/cell therapies of muscle diseases. Current projects focus on iPS cell-derived myogenesis and bioengineering for complex neuromuscular disease and therapy modelling. The overall goal of the Tedesco laboratory is the translation of regenerative strategies into novel therapies to improve future outcomes for children with neuromuscular disorders.


Our work pioneered the use of human artificial chromosomes and induced pluripotent stem (iPS) cells for muscle gene and cell therapies (Tedesco et al., Sci Transl Med 2011 and 2012; Maffioletti & Gerli et al., Nat Protoc 2015; Benedetti et al., EMBO Mol Med 2018). Current research projects are also investigating the use of small molecules to improve muscle stem cell delivery (Gerli & Moyle et al., Stem Cell Reports 2019) 


We have reported the first isogenic, 3D human iPSC-derived, multilineage artificial skeletal muscle for complex disease modelling and beyond (Maffioletti & Sarcar, Cell Reports 2019). Current projects are focusing on extending this platform to tissue replacement, drug screening and therapy development for acute & chronic muscle/neuromuscular diseases. 


We are adapting our gene/cell therapy and tissue engineering platforms to model severe and incurable neuromuscular diseases (Steele-Stallard HB et al., Front Physiol 2018). We started with skeletal muscle laminopathies and are currently investigating strategies to model several other neuromuscular disorders using iPSCs in 2D and 3D cultures.


UCL Dept. of Cell & Developmental Biology

Rockefeller /Medical School Building
21 University Street 

WC1E 6DE, London, UK 

UCL  web page (IRIS)

The Francis Crick Institute

1 Midland Road 

NW1 1AT, London, UK

Crick lab website

  • Follow us on Twitter

Current and Recent Funders

Screenshot 2024-06-03 at 11.03.23 (3).png
bottom of page